Gemcitabine enhances cytotoxic activity of effector T-lymphocytes against chemo-resistant cholangiocarcinoma cells.

Sawasdee, Nunghathai

Gemcitabine enhances cytotoxic activity of effector T-lymphocytes against chemo-resistant cholangiocarcinoma cells. [electronic resource] - International immunopharmacology Jan 2020 - 106006 p. digital

Publication Type: Journal Article

1878-1705

10.1016/j.intimp.2019.106006 doi


Antineoplastic Agents--pharmacology
Bile Duct Neoplasms--therapy
Cell Line, Tumor
Cholangiocarcinoma--therapy
Dendritic Cells--immunology
Deoxycytidine--analogs & derivatives
Drug Resistance, Neoplasm
Humans
T-Lymphocytes, Cytotoxic
Gemcitabine